Posted on 08/06/2021 9:18:02 AM PDT by nickcarraway
Moderna reported better-than-expected earnings and said that its vaccine is more than 90% effective after six months, but that wasn’t enough to push the company’s stock, which has more than doubled during the past three months.
Moderna (ticker: MRNA) reported a June quarter profit of $6.46 cents a share, beating forecasts for $6.04. Its sales of $4.4 billion were ahead of expectations for $4.28 billion. Moderna also said it would buy back $1 billion worth of shares over the next two years.
(Excerpt) Read more at barrons.com ...
And if you believe that... I have a bridge in Brooklyn I would like to sell you. The mRNA vaccines have been dropping in effectiveness by a rate of 10% a week recently. Their longevity is in the end stages. It is time to club them on the head out of kindness.
I'm getting better!
Fauci should fund more Chinese ‘gain of function’ studies, so that more deadly viruses can be released into the world, thereby making Moderna and Pfizer and J&J richer.
Wonder how much drug companies’ stock Fauci and democrats own.
I’ve seen plenty of stories on Pfizer and even that company working on a booster shot but relatively little on moderna.
Pretty good for a company that never made a vaccine before.
There are a several frequent posters to this forum who will be following this story very carefully.
Disclaimer: Opinions posted on Free Republic are those of the individual posters and do not necessarily represent the opinion of Free Republic or its management. All materials posted herein are protected by copyright law and the exemption for fair use of copyrighted works.